Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| Adrafinil | Gotu Kola (Centella asiatica) | |
|---|---|---|
| Category | Nootropics | Nootropics |
| Standard Dose | 300-600 mg once daily (for educational context — unregulated prodrug of a prescription medication) | 500-1000 mg/day of standardized extract (35-45% triterpenes) or 750-1500 mg/day of whole herb extract |
| Timing | Early morning on an empty stomach for faster hepatic conversion. Onset delayed 60-90 minutes. Avoid afternoon/evening dosing due to long effective duration. | Morning or split morning/afternoon. With or without food. Acute mood effects (alertness, reduced anger) noted within 1 hour of dosing. |
| Cycle Duration | Short-term or intermittent use strongly preferred. Avoid continuous daily use exceeding 3 months without liver function monitoring. | Ongoing; traditional use suggests no cycling required. Clinical trials run 2-6 months. |
| Evidence Level | moderate_human | moderate_human |
Inactive prodrug that is hepatically metabolized to modafinil (via hepatic amidase enzymes) and its inactive acid metabolite modafinilic acid. The active metabolite modafinil then exerts its effects as a DAT inhibitor with downstream orexinergic, histaminergic, and noradrenergic activation. Conversion is incomplete — approximately 33-50% of adrafinil is converted to modafinil, with the remainder forming inactive metabolites. The hepatic first-pass metabolism means onset is delayed (60-90 minutes vs. 30-60 minutes for modafinil).
300-600 mg once daily (for educational context — unregulated prodrug of a prescription medication)
Early morning on an empty stomach for faster hepatic conversion. Onset delayed 60-90 minutes. Avoid afternoon/evening dosing due to long effective duration.
Short-term or intermittent use strongly preferred. Avoid continuous daily use exceeding 3 months without liver function monitoring.
Pentacyclic triterpenes — asiaticoside, madecassoside, asiatic acid, and madecassic acid — provide neuroprotection through multiple mechanisms: inhibition of acetylcholinesterase activity and enhancement of cholinergic transmission; reduction of phospholipase A2 (PLA2) activity to attenuate neuroinflammation; protection against beta-amyloid aggregation and tau hyperphosphorylation; and upregulation of BDNF to promote neuronal growth and synaptic plasticity. Asiaticoside enhances collagen synthesis and wound healing, while asiatic acid activates the MAPK/ERK pathway to promote neurite outgrowth.
500-1000 mg/day of standardized extract (35-45% triterpenes) or 750-1500 mg/day of whole herb extract
Morning or split morning/afternoon. With or without food. Acute mood effects (alertness, reduced anger) noted within 1 hour of dosing.
Ongoing; traditional use suggests no cycling required. Clinical trials run 2-6 months.
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →